Your browser doesn't support javascript.
loading
Does body mass index predict response to intravenous ketamine treatment in adults with major depressive and bipolar disorder? Results from the Canadian Rapid Treatment Center of Excellence.
Lipsitz, Orly; McIntyre, Roger S; Rodrigues, Nelson B; Lee, Yena; Gill, Hartej; Subramaniapillai, Mehala; Kratiuk, Kevin; Nasri, Flora; Mansur, Rodrigo B; Rosenblat, Joshua D.
Affiliation
  • Lipsitz O; Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Ontario, Canada.
  • McIntyre RS; Canadian Rapid Treatment Center of Excellence, Mississauga, Ontario, Canada.
  • Rodrigues NB; Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Ontario, Canada.
  • Lee Y; Canadian Rapid Treatment Center of Excellence, Mississauga, Ontario, Canada.
  • Gill H; Brain and Cognition Discovery Foundation, Toronto, Ontario, Canada.
  • Subramaniapillai M; Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada.
  • Kratiuk K; Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Ontario, Canada.
  • Nasri F; Canadian Rapid Treatment Center of Excellence, Mississauga, Ontario, Canada.
  • Mansur RB; Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Ontario, Canada.
  • Rosenblat JD; Canadian Rapid Treatment Center of Excellence, Mississauga, Ontario, Canada.
CNS Spectr ; 27(3): 322-330, 2022 06.
Article in En | MEDLINE | ID: mdl-33267928

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Bipolar Disorder / Depressive Disorder, Major / Depressive Disorder, Treatment-Resistant / Ketamine Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Humans Country/Region as subject: America do norte Language: En Journal: CNS Spectr Journal subject: NEUROLOGIA Year: 2022 Document type: Article Affiliation country:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Bipolar Disorder / Depressive Disorder, Major / Depressive Disorder, Treatment-Resistant / Ketamine Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Humans Country/Region as subject: America do norte Language: En Journal: CNS Spectr Journal subject: NEUROLOGIA Year: 2022 Document type: Article Affiliation country: